Michael R Megna

CHIEF ACCOUNTING OFFICER · Kiniksa Pharmaceuticals International

Michael R Megna (CHIEF ACCOUNTING OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $3.4M of KNSA (36,260 sh across 7 lots, as filed), executed Oct 30. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.1M

shares × price, as filed

Last traded

Oct 30

Filed Nov 3

Median ADV $60.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 10 sells 10 filings

Recent filings

KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $3.4M
36,260 sh across 7 lots
Exec Oct 30
Filed Nov 3 · 6:26 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $369K
4,600 sh × $80.30
Exec Sep 3
Filed Sep 3 · 4:40 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $309K
6,625 sh × $46.69
Exec Apr 9
Filed Apr 13 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.0M
50,490 sh across 2 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $383K
11,000 sh × $34.84
Exec Sep 3 2025
Filed Sep 3 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $550K
17,000 sh × $32.35
Exec Aug 4 2025
Filed Aug 6 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $437K
15,211 sh × $28.75
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $471K
17,647 sh × $26.69
Exec May 7 2025
Filed May 9 2025 · 5:30 PM ET More filings →